Gyre Therapeutics Inc. Long-term Investment Intensity
Gyre Therapeutics Inc. long-term investment intensity. Gyre Therapeutics Inc. (GYRE) has a Long-term Investment Intensity of 18.2% as of March 2026. Long-term investments of $29.42 Million represent 18.2% of total assets of $162.01 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Gyre Therapeutics Inc. total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Gyre Therapeutics Inc. (2022–2025)
Long-term investment intensity of Gyre Therapeutics Inc. from 2022 to 2025. This chart shows how Gyre Therapeutics Inc.'s Long-term Investment Intensity has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the intensity stands at 18.2%, reflecting long-term investments of $29.42 Million against total assets of $162.01 Million USD.
Gyre Therapeutics Inc. Long-term Investment Intensity by Year (2022–2025)
Gyre Therapeutics Inc. long-term investment intensity by year from 2022 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Gyre Therapeutics Inc. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Gyre Therapeutics Inc. asset portfolio.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 14.2% | $23.52 Million | $166.13 Million | ▼ -5.4 pp |
| 2024 | 19.6% | $24.57 Million | $125.41 Million | ▼ -0.5 pp |
| 2023 | 20.1% | $23.43 Million | $116.54 Million | ▲ +11.4 pp |
| 2022 | 8.7% | $7.39 Million | $84.75 Million | — |